Study of Rasagiline in Parkinson's Disease Patients Using Levodopa

Study Title
Multicenter Study of Rasagiline in Parkinson's Disease Patients Using Levodopa and Experiencing Motor Fluctuations
Teva Identifier
TV-1012/133
ClinicalTrials.gov Identifier
NCT00203034
Study Status
Completed
Trial Condition(s)
Parkinson's Disease
Interventions
Drug: rasagiline mesylate | Drug: 1.0 mg rasagiline mesylate | Other: Placebo

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Print

Click for participation criteria and map of study locations


Key Participation Requirements

Gender
Female, Male
Age Range
30 Years and older
Trial Duration
05/01/2000 - 01/01/2003
Phase
Phase 3

Study Type

Interventional